EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--April 6, 2005--SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, today announced that it will host a live Webcast of its fiscal 2005 second quarter conference call on Wednesday, April 20, at 4:00 p.m. CT. The Company will issue an earnings news release after the market closes that afternoon.

Dale Olseth, Chairman and Chief Executive Officer, Bruce Barclay, President and Chief Operating Officer, and Phil Ankeny, Chief Financial Officer and Vice President, Business Development, will recap the second quarter financial results and accomplishments. To access the Webcast, go to the investor relations portion of the Company's Web site, www.surmodics.com, on the day of the conference call and click on the Webcast icon. If you do not have access to the Internet and want to listen to the audio, dial 800-240-2430.

An audio replay will be available beginning at 6:00 p.m. CT on Wednesday, April 20, until 6:00 p.m. CT on Wednesday, April 27 and can be accessed by dialing 800-405-2236 and entering conference call ID 11027932. In addition, the conference call audio will be archived on the Company's Web site following the call.

About SurModics, Inc.

SurModics, Inc., a leading provider of surface modification and drug delivery solutions, licenses its proprietary technologies to medical device, diagnostics, and biotechnology companies around the world. A significant portion of SurModics' revenue is generated through royalties on the sale of coated products. SurModics' Internet address is www.surmodics.com.

CONTACT: SurModics, Inc.
Phil Ankeny, 952-829-2700

SOURCE: SurModics, Inc.